Renal function is stable in islet cell transplant recipients treated with tacrolimus and mycophenolate for maintenance immunosuppression

被引：0
|
作者：
Thompson, David M.
Al Ghofaili, Khalid M.
Fung, Michelle A.
Ao, Ziliang
Keown, Paul
Meloche, R. M.
Shapiro, R. J.
Ho, Stephen
Worsley, Dan
Meneilly, Graydon S.
Kozak, Sharon E.
Tong, Suet On
Trinh, Mary
Blackburn, Lorraine
Kozak, Robert M.
Fensom, Blake A.
Warnock, Garth L.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A46 / A46
页数：1
相关论文
共 50 条
  • [1] A Novel Formula to Determine Optimal Immunosuppression in Renal Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: Towards Individualized Immunosuppression
    Pankewycz, O.
    Laftavi, M.
    Onan, E.
    Rucker, D.
    Wang, D.
    Bhuta, K.
    Gruessner, R.
    Gruessner, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 668 - 669
  • [2] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
  • [3] Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients:: Preliminary report in Chile
    Mueller, H.
    Solari, S.
    Zuniga, C.
    Pedreros, C.
    Troncoso, J.
    Morente, C.
    Ovalle, R.
    Acosta, P.
    Chavez, T.
    Albornoz, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (03) : 705 - 707
  • [4] Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients
    Roth, D
    Colona, J
    Burke, GW
    Ciancio, G
    Esquenazi, V
    Miller, J
    [J]. TRANSPLANTATION, 1998, 65 (02) : 248 - 252
  • [5] Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
    Ciancio, G
    Miller, A
    Burke, GW
    Gharagozloo, H
    Rosen, A
    Roth, D
    Kupin, W
    Pinna, A
    Cespedes, M
    Esquenazi, V
    Miller, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1013 - 1014
  • [6] Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients
    Forsythe, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (7A) : 69S - 71S
  • [7] EVEROLIMUS (EVE) ASSOCIACTED TO TACROLIMUS (TAC) IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS AS IMMUNOSUPPRESSION TREATMENT
    Rengel, Manuel
    Abad, Soraya
    Vega, Almudena
    Verde, Eduardo
    Verdalles, Ursula
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 748 - 748
  • [8] Renal function in long term hand transplant recipients: Impact of tacrolimus and immunosuppression
    Breidenbach, Warren C.
    Ravindra, Kadiyala V.
    Marvin, Micheal
    Buell, Joseph F.
    Blair, Brenda W.
    Kaufman, Christina L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 490 - 490
  • [9] Corticosteroid minimization in pediatric renal transplant recipients under thymoglobulin, tacrolimus and mycophenolate mofetil immunosuppression.
    Smith, LD
    Somerville, KT
    Holman, J
    Sherbotie, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 647A - 647A
  • [10] Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil and steroids as maintenance immunosuppression.
    Roth, D
    Kuehnel, F
    Angelis, M
    Colona, J
    Burke, G
    Ciancio, G
    Esquenazi, V
    Miller, J
    [J]. TRANSPLANTATION, 1999, 67 (09) : S602 - S602
12345